Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Friday, September 18, 2026

Daily orforglipron treatment reduces weight and blood sugar in seniors

›
In continuation of my update on  orforglipron A new analysis to be presented at this year's European Congress on Obesity (ECO 2026, Ista...
Thursday, September 17, 2026

Semaglutide shows sustained weight loss benefits in older adults

›
In continuation of my update on semaglutide A new analysis of the STEP trails carried out by semaglutide manufacturer Novo Nordisk has analy...
Wednesday, September 16, 2026

Glutamic Acid Helps Fresh-Cut Potatoes Stay Fresh by Silencing Browning Genes | Newswise

›
In continuation of my update on Glutamic acid  The study identified a transcriptional regulatory module, StbZIP53-like2–StERF091, that suppr...
Saturday, September 12, 2026

Legumes and soy foods may help reduce hypertension risk

›
In continuation of my continuation of my update on soy .. A higher dietary intake of soy and legumes is linked to a lower risk of high bloo...
Friday, September 11, 2026

Nicotinamide Linked to Lower Melanoma Risk Post Skin Cancer

›
In continuation of my update on Nicotineamide Nicotinamide supplementation was associated with a decreased risk for melanoma among patients ...
Wednesday, September 9, 2026

Metformin's real power may be in the gut

›
In continuation of my uodate on metformin  For decades, physicians and scientists thought metformin, the leading type 2 diabetes medication ...
Tuesday, September 8, 2026

FDA Approves Veppanu (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer

›
Arvinas, Inc. (Nasdaq: ARVN), with its partner Pfizer Inc. (NYSE: PFE), announced  the U.S. Food and Drug Administration (FDA)    approval f...
Monday, September 7, 2026

Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST)

›
Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases,...
Thursday, September 3, 2026

Nuvalent Announces Submission of New Drug Application to FDA for Neladalkib in TKI Pre-treated Advanced ALK-Positive NSCLC

›
Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically pr...
Wednesday, September 2, 2026

Some Improvement Seen in Cognitive Function With Exercise, Ibuprofen in Cancer

›
In continution of my update on Ibuprofen  For adults with cancer receiving chemotherapy, an exercise intervention and low-dose ibuprofen imp...
Tuesday, September 1, 2026

Combining Cannabinoid With Opioid Does Not Relieve Pain in Knee Osteoarthritis

›
For patients with knee osteoarthritis, combining a cannabinoid medication with an  opioid  does not provide additional pain relief, accordin...
Monday, August 31, 2026

FDA Approves Idvynso (doravirine and islatravir) for the Treatment of HIV-1 Infection in Adults

›
In continuation of my update on   Doravirine Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced the U.S. Foo...
Saturday, August 29, 2026

Injectable peptides are the new anti‑aging trend. But what evidence do we have they're safe for humans?

›
Injectable peptides are the new anti-aging trend sweeping the beauty industry. These compounds are promoted on social media as tools for ski...
Thursday, August 27, 2026

Experimental drug cuts Parkinson's-linked protein up to 60% in early trial

›
An experimental drug designed to silence a gene strongly linked to Parkinson's disease has shown encouraging effects in a first-in-human...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.